DGX files Form 144 to sell common shares

DGX filed a Form 144 indicating planned sales of common stock following restricted stock vesting.

Rhea-AI Filing Summary

DGX filed a Form 144 indicating planned sales of common stock following restricted stock vesting. The notice lists 480 shares with a 02/12/2026 date and 631 shares with a 02/14/2026 date, with transactions routed through Fidelity Brokerage Services LLC.

Insights

Insider Transactions Specialist

Planned sales tied to vested awards are administrative and routine.

The filing lists common shares associated with restricted stock vesting dated 02/12/2026 (480 shares) and 02/14/2026 (631 shares), processed through Fidelity Brokerage Services LLC.

These entries reflect forthcoming dispositions by holders; timing and final execution depend on holder decisions and brokerage handling. Subsequent filings would confirm actual sales and proceeds.

FAQ

What does DGX's Form 144 disclose about share amounts?

The Form 144 lists 480 shares dated 02/12/2026 and 631 shares dated 02/14/2026. These figures appear under the securities-to-be-sold entries tied to restricted stock vesting.

Who is the broker handling the transactions in the DGX filing?

The filing identifies Fidelity Brokerage Services LLC at 900 Salem Street, Smithfield, RI as the broker. The broker is listed in the securities and routing information for the planned transactions.

Are the DGX shares from sales or vesting events?

The entries are labeled as Restricted Stock Vesting and list the issuer as the source, indicating the shares arise from vesting events and are listed for sale in this notice.

Does the filing show proceeds or pricing for the planned sales?

The provided excerpt does not state sale prices or aggregate proceeds. It lists share counts and dates but does not disclose dollar amounts or execution prices for the transactions.

When were the transactions in DGX's Form 144 dated?

The securities-to-be-sold entries show dates of 02/12/2026 and 02/14/2026, and a form-related date of 02/19/2026 appears in the filing header.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/19/2026 - 10:19 AM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001222679
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	QUEST DIAGNOSTICS INC
SEC File Number	001-12215
Address of Issuer	500 PLAZA DRIVE SECAUCUS NEW JERSEY 07094
Phone	9735202700
Name of Person for Whose Account the Securities are To Be Sold	PREVOZNIK MICHAEL E
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	1111	227566.13	111242362	02/19/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/12/2026	Restricted Stock Vesting	Issuer			480	02/12/2026	Compensation
Common	02/14/2026	Restricted Stock Vesting	Issuer			631	02/14/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	02/19/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	05/30/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Daniel Tucci, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Michael Prevoznik
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)